XML Financial’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,614
Closed -$272K 441
2025
Q4
$272K Buy
+1,614
New +$262K 0.02% 357
2024
Q4
Sell
-2,447
Closed -$356K 368
2024
Q3
$356K Sell
2,447
-320
-12% -$46.3K 0.03% 273
2024
Q2
$380K Sell
2,767
-251
-8% -$33.5K 0.04% 249
2024
Q1
$414K Buy
3,018
+2
+0.1% +$273 0.04% 245
2023
Q4
$410K Buy
3,016
+255
+9% +$31.1K 0.04% 231
2023
Q3
$338K Hold
2,761
0.04% 244
2023
Q2
$350K Buy
2,761
+1
+0% +$130 0.04% 255
2023
Q1
$357K Buy
2,760
+1
+0% +$131 0.04% 247
2022
Q4
$362K Buy
2,759
+73
+3% +$9.43K 0.05% 237
2022
Q3
$314K Buy
2,686
+3
+0.1% +$373 0.04% 241
2022
Q2
$316K Buy
2,683
+475
+22% +$56.4K 0.07% 171
2022
Q1
$288K Buy
2,208
+198
+10% +$25.8K 0.03% 266
2021
Q4
$307K Buy
+2,010
New +$311K 0.04% 258

Other funds holding IBB